Skip to ContentSkip to Navigation
Over ons Praktische zaken Waar vindt u ons prof. dr. M.J. (Maarten) Postma

prof. dr. M.J. (Maarten) Postma

Hoogleraar Global Health Economics UMCG & RUG (Medische en Economie & Bedrijfskunde faculteiten)
Profielfoto van prof. dr. M.J. (Maarten) Postma
Telefoon:
050 361 5084 (secretariaat)
E-mail:
m.j.postma rug.nl

Publicaties

A cost-minimization analysis of anti-VEGFs for the treatment of neovascular age-related macular degeneration in the Netherlands

Cost-Effectiveness of Trastuzumab Deruxtecan in Patients with Unresectable or Metastatic HER2-Low Breast Cancer Who Have Received Prior Chemotherapy

Early economic evaluation of chelation therapy in kidney transplant recipients with high-normal lead

Long-term effectiveness of a digital inhaler on medication adherence and clinical outcomes in adult asthma patients in primary care: the cluster randomised controlled ACCEPTANCE trial

Lung cancer screening with volume computed tomography is cost-effective in Greece

Absenteeism and Productivity Loss Due to Influenza or Influenza-like Illness in Adults in Europe and North America

A clinical and economic assessment of adjuvanted trivalent versus standard egg-derived quadrivalent influenza vaccines among older adults in the United States during the 2018-19 and 2019-20 influenza seasons

A cost analysis of a simplified model for HCV screening and treatment at a tertiary hospital in Zimbabwe

A Dutch cost-effectiveness analysis of fremanezumab versus best supportive care in patients with chronic migraine and inadequate response to prior preventive therapy

Pers/media

Maarten Postma: Cost-effectiveness is stick for Big Pharma

The Office of Health Economics

The Office of Health Economics: Adult Vaccination Programmes Deliver Socio-